Private company

Agriculture & Natural Solutions Acquisition Corp

Blank check company in the Cayman Islands1

In its 2026 annual report the company says: “We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.”4 It is headquartered in New York, New York.1

Last updated Oct 20, 2026.

Overview

$10.5MNet income, fiscal 20252
  • IndustryBlank Checks1
  • HeadquartersNew York, New York1
  • Incorporated inCayman Islands3
  • Business address712 Fifth Ave., 36Th Floor, New York, Ny 100193
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income562-$5.5M in 2025+448757% since 2022
-$15.0M-$10.0M-$5.0M02022: -$1.2K-$1.2K20222023: -$1.2M-$1.2M2023+93896%2024: -$10.2M-$10.2M2024+789%2025: -$5.5M-$5.5M2025−46%
Net income562$10.5M in 2025
-$5.0M0$5.0M$10.0M$15.0M2022: -$1.2K-$1.2K20222023: $1.3M$1.3M20232024: $8.4M$8.4M2024+541%2025: $10.5M$10.5M2025+25%
Fiscal year20212022202320242025
Operating income-$1.2K5-$1.2M6-$10.2M2-$5.5M2
Net income-$1.2K5$1.3M6$8.4M2$10.5M2

Compare Agriculture & Natural Solutions Acquisition Corp with another company

Corporate structure

Agriculture & Natural Solutions Acquisition Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Agriculture & Natural Solutions Acquisition Corp

  • Fort Baker Capital Management LP Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Aug 14, 2026 (2 filings since Feb 17, 2026)
  • Goldman Sachs Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Aug 11, 2026 (2 filings since Nov 10, 2025)
  • First Trust Capital Management L.P. Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest May 15, 2026 (4 filings since Feb 28, 2024)
  • GLAZER CAPITAL, LLC Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest May 14, 2026 (5 filings since Feb 14, 2025)
  • Westchester Capital Management, LLC Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Feb 13, 2026 (2 filings since Feb 14, 2025)
  • WOLVERINE ASSET MANAGEMENT LLC Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Feb 2, 2026 (2 filings since Jul 21, 2025)
  • Wealthspring Capital LLC Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Oct 14, 2025 (2 filings since Mar 8, 2024)
  • COWEN AND COMPANY, LLC Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest May 12, 2025 (3 filings since Feb 2, 2024)
  • Barclays Filed SCHEDULE 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Mar 21, 2025 (4 filings since Nov 13, 2024)
  • AQR CAPITAL MANAGEMENT LLC Filed SC 13G on Agriculture & Natural Solutions Acquisition Corp, latest Nov 14, 2024
  • JPMorgan Chase Filed SC 13G/A on Agriculture & Natural Solutions Acquisition Corp, latest Nov 5, 2024 (2 filings since Oct 23, 2024)
  • Agriculture & Natural Solutions Acquisition Sponsor LLC Filed SC 13G on Agriculture & Natural Solutions Acquisition Corp, latest Feb 8, 2024
  • Agriculture & Natural Solutions Acquisition Corp New York, New York

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Agriculture & Natural Solutions Acquisition Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Properties, in its own words

Our executive offices are located at 712 Fifth Avenue, 36th Floor, New York, NY 10019. The cost for our use of this space is included in the $10,000 per month we pay to an affiliate of our Sponsor for office space, utilities, secretarial support and administrative services. We consider our current office space adequate for our current operations.

Item 2 of the 10-K filed Mar 27, 2026.4

Leadership

Who has led Agriculture & Natural Solutions Acquisition Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Robert James Glover2023
2025
Board members and other officers (6)

Former names

  • Decarbonization Plus Acquisition Corp VSep 2, 2021 to Dec 5, 20223

Timeline

  1. Aug 18, 20268-K Listing notice or transfer17
  2. Jul 31, 20268-K Other events18
  3. Nov 12, 20258-K Entered a material agreement; New debt or obligation; Unregistered sale of shares19
  4. Oct 14, 20258-K Other events20
  5. Jun 26, 20258-K Shareholder vote21
  6. Apr 11, 20258-K Entered a material agreement; Ended a material agreement22
  7. Feb 14, 20258-K Listing notice or transfer23
  8. Dec 16, 20248-K Other events24
  9. Sep 19, 20248-K Regulation FD disclosure25
  10. Aug 29, 20248-K Entered a material agreement; New debt or obligation; Listing notice or transfer26
  11. May 1, 20248-K Listing notice or transfer27
  12. Jan 2, 20248-K Other events28
  13. Nov 8, 2023New chief executive Robert James Glover becomes CEO11

Filings

98 filings to the SEC since October 2021: 4 annual reports, 9 quarterly reports, 15 major events, 10 insider forms, 30 large holders, 30 other. The latest 20:

  1. Aug 18, 20268-K EDGAR
  2. Aug 14, 2026SCHEDULE 13G/A EDGAR
  3. Aug 14, 202610-Q EDGAR
  4. Aug 11, 2026SCHEDULE 13G/A EDGAR
  5. Jul 31, 20268-K EDGAR
  6. May 15, 2026SCHEDULE 13G/A EDGAR
  7. May 14, 202610-Q EDGAR
  8. May 14, 2026SCHEDULE 13G/A EDGAR
  9. Mar 27, 202610-K EDGAR
  10. Feb 17, 2026SCHEDULE 13G EDGAR
  11. Feb 13, 2026SCHEDULE 13G/A EDGAR
  12. Feb 2, 2026SCHEDULE 13G/A EDGAR
  13. Nov 12, 202510-Q EDGAR
  14. Nov 12, 20258-K EDGAR
  15. Nov 10, 2025SCHEDULE 13G/A EDGAR
  16. Oct 14, 2025DEFA14A EDGAR
  17. Oct 14, 20258-K EDGAR
  18. Oct 14, 2025SCHEDULE 13G/A EDGAR
  19. Oct 10, 2025DEF 14A EDGAR
  20. Aug 20, 2025PRE 14A EDGAR

The 98 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Agriculture & Natural Solutions Acquisition Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAgriculture & Natural Solutions Acquisition Corp1
  • CIK0001854149
  • Employer ID (EIN)98-15916194
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inCayman Islands4
  • Fiscal year endsDecember 311
  • Industry code (SIC)6770 Blank Checks1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business address712 Fifth Ave., 36Th Floor, New York, NY 100191
  • Phone(212) 271-62471
  • Shares outstanding32,922,237 Common Class A shares; 8,625,000 Common Class B shares as of Mar 27, 20264
  • Public float$374.3M as of Jun 30, 20254
  • AuditorWithumSmith+Brown, PC, New York, New York PCAOB ID 100; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceSep 2, 20211
  • Filings106 in all: SCHEDULE 13G/A (16), 8-K (14), SCHEDULE 13G (11), 425 (10), 10-Q (9), 3 (7), SC 13G (6), 10-K (3)1
    All 28 form types

    CORRESP (3), S-1/A (3), SC 13G/A (3), 4 (2), DEF 14A (2), DRS (2), S-1 (2), 10-K/A (1), 25-NSE (1), 3/A (1), 424B4 (1), 8-A12B (1), 8-K/A (1), ARS (1), CERT (1), DEFA14A (1), EFFECT (1), PRE 14A (1), SEC STAFF ACTION (1), UPLOAD (1)

  • Latest filingsAnnual report (10-K) Mar 27, 2026
    Quarterly report (10-Q) Aug 14, 2026
    Proxy statement (DEF 14A) Oct 10, 2025
    Latest 8-K (8-K) Aug 18, 2026

Securities registered for trading

ClassSymbolExchange
Units, each consisting of one Class A ordinary share and one-half of one warrantANSCUThe Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per shareANSCThe Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per shareANSCWThe Nasdaq Stock Market LLC

From the cover page of the 10-K filed Mar 27, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Agriculture & Natural Solutions Acquisition Corp names in Item 1A of its 10-K filed Mar 27, 2026: 76 risks under these headings, as written.4

  • Risks Relating to a Special Purpose Acquisition Company and our Securities
  • Risks Relating to our Securities
  • Risks Relating to the Sponsor Entities, our Sponsor and Our Management Team
  • I. Risks Relating to a Special Purpose Acquisition Company and our Securities
  • We are a company with no operating history and no revenues (other than interest earned on the funds held in the Trust Account), and you have no basis on which to evaluate our ability to achieve our business objective.
  • Our public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination.
  • If we seek shareholder approval of our initial business combination, our initial shareholders have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
  • Your only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek shareholder approval of such business combination.
  • The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
  • The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.
  • The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.
  • The requirement that we complete our initial business combination by the Extended Termination Date may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine our ability to complete our business combination on terms that would produce value for our shareholders.
The other 67 risks
  • We may not be able to complete our initial business combination by the Extended Termination Date, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholder may only receive $10.00 per share, or less than such amount in certain circumstances, and our Warrants will expire worthless.
  • Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.”
  • We may not be able to complete an initial business combination because such initial business combination may be subject to regulatory review and approval requirements, including foreign investment regulations and review by government entities such as the Committee on Foreign Investment in the United States (“CFIUS”), or may be ultimately prohibited.
  • As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
  • If we seek shareholder approval of our initial business combination, our Sponsor, directors, officers, advisors and their affiliates may elect to purchase shares or Warrants from public shareholders or public warrantholders, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares.
  • Members of our management team and board of directors have significant experience as founders, board members, officers, executives or employees of other companies. Certain of those persons have been, are currently, or may become, involved in litigation, investigations or other proceedings, including related to those companies or otherwise. This may have an adverse effect on us, which may impede our ability to consummate an initial business combination.
  • If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.
  • You will not have any rights or interests in funds from the Trust Account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or Warrants, potentially at a loss.
  • II. Risks Relating to our Securities
  • NASDAQ may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.
  • Since only holders of our Founder Shares will have the right to vote on the election of directors prior to our initial business combination, NASDAQ considers us to be a “controlled company” within the meaning of NASDAQ’s rules and, as a result, we qualify for exemptions from certain corporate governance requirements that would otherwise provide protection to shareholders of other companies.
  • You will not be entitled to protections normally afforded to investors of many other blank check companies.
  • If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 20% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 20% of our Class A ordinary shares.
  • Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable to complete our initial business combination, our public shareholders may receive only their pro rata portion of the funds in the Trust Account that are available for distribution to public shareholders, and our Warrants will expire without value to the holder.
  • If the net proceeds of our Public Offering and the sale of the Private Placement Warrants not being held in the Trust Account are insufficient to allow us to operate until at least the Extended Termination Date, we may be unable to complete our initial business combination, in which case our public shareholders may only receive $10.00 per share, or less than such amount in certain circumstances, and our Warrants will expire worthless.
  • Subsequent to our completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our share price, which could cause you to lose some or all of your investment.
  • If third parties bring claims against us, the proceeds held in the Trust Account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per share.
  • Our directors may decide not to enforce the indemnification obligations of our Sponsor, resulting in a reduction in the amount of funds in the Trust Account available for distribution to our public shareholders.
  • If, after we distribute the proceeds in the Trust Account to our public shareholders, we file a winding up petition or a winding up petition is filed against us that is not dismissed, a liquidator may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby potentially exposing the members of our board of directors and us to claims of punitive damages.
  • If, before distributing the proceeds in the Trust Account to our public shareholders, we file a winding up petition or a winding up petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.
  • If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete an initial business combination.
  • Our search for a business combination, and any target businesses with which we ultimately consummate a business combination, may be materially adversely affected by the status of the debt and equity markets.
  • Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.
  • We may not hold another annual general meeting of shareholders until after the consummation of our initial business combination, which could delay the opportunity for our shareholders to elect directors.
  • You will not be permitted to exercise your Warrants unless we register and qualify the issuance of the underlying Class A ordinary shares or certain exemptions are available.
  • The grant of registration rights to our initial shareholders may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our Class A ordinary shares.
  • Because we are not limited to a particular industry, sector or any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’s operations.
  • Whether a redemption of Class A ordinary shares will be treated as a sale of such Class A ordinary shares for U.S. federal income tax purposes will depend on a shareholder’s specific facts.
  • We are likely treated as a passive foreign investment company (“PFIC”), which could result in adverse U.S. federal income tax consequences to U.S. investors.
  • We may, without prior notice or shareholder approval, change our jurisdiction of incorporation, which may result in adverse legal, tax or other consequences to us, our shareholders and/or warrantholders.
  • If our initial business combination involves a company organized under the laws of the United States (or any subdivision thereof), a 1% U.S. federal excise tax could be imposed on us in connection with redemptions of our Class A ordinary shares after or in connection with such initial business combination.
  • III. Risks Relating to the Sponsor Entities, our Sponsor and Our Management Team
  • Past performance by the Sponsor Entities, including our management team, may not be indicative of future performance of an investment in us.
  • We may seek acquisition opportunities in industries or sectors which may or may not be outside of our management’s area of expertise.
  • Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.
  • We may seek acquisition opportunities with an early stage company, a financially unstable business or an entity lacking an established record of revenue or earnings, which could subject us to volatile revenues, cash flows or earnings or difficulty in retaining key personnel.
  • We are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to the Company from a financial point of view.
  • Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders may only receive their pro rata portion of the funds in the Trust Account that are available for distribution to public shareholders, and our Warrants will expire without value to the holder.
  • We are dependent upon our officers and directors, and their loss could adversely affect our ability to operate.
  • Our ability to successfully effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.
  • Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following our business combination and, as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
  • Our current officers may not remain in their positions following our business combination. We may have a limited ability to assess the management of a prospective target business and, as a result, may affect our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company, which could, in turn, negatively impact the value of our shareholders’ investment in us.
  • Our officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.
  • Certain of our officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in allocating their time and determining to which entity a particular business opportunity should be presented.
  • Our officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
  • We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our Sponsor, officers, directors or existing holders which may raise potential conflicts of interest.
  • Since our Sponsor, officers and directors will lose their entire investment in us if our business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.
  • We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.
  • We may only be able to complete one business combination with the proceeds of our Public Offering and the sale of the Private Placement Warrants, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.
  • We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.
  • We may attempt to complete our initial business combination with a private company about which little information is available, which may result in a business combination with a company that is not as profitable as we suspected, if at all.
  • Our management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.
  • We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete a business combination with which a substantial majority of our shareholders do not agree.
  • In order to effectuate our initial business combination, we may seek to amend our amended and restated memorandum and articles of association or other governing instruments, including our warrant agreement, in a manner that will make it easier for us to complete our initial business combination but that our shareholders or warrantholders may not support.
  • We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon a particular business combination. If we are unable to complete our initial business combination, our public shareholders may only receive their pro rata portion of the fund in the Trust Account that are available for distribution to public shareholders, and our Warrants will expire without value to the holder.
  • Our initial shareholders will control the appointment and removal of our board of directors until consummation of our initial business combination and will hold a substantial interest in us. As a result, they will appoint and remove all of our directors prior to our initial business combination and may exert a substantial influence on actions requiring a shareholder vote and board approval, potentially in a manner that you do not support.
  • We may amend the terms of the Warrants in a manner that may be adverse to holders of Warrants with the approval by the holders of at least 50% of the then-outstanding Warrants. As a result, the exercise price of your Warrants could be increased, the Warrant could be converted into cash or shares (at a ratio different than initially provided), the exercise period could be shortened and the number our Class A ordinary shares purchasable upon exercise of a Warrant could be decreased, all without your approval.
  • We may redeem your unexpired Warrants prior to their exercise at a time that is disadvantageous to you, thereby making your Warrants worthless.
  • Our Warrants and Founder Shares may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our business combination.
  • The conversion of the Extension Promissory Note upon consummation of our business combination into warrants may have an adverse effect on the market price of our ordinary shares and make it more difficult to effect a business combination.
  • Because each Unit contains one-half of one Warrant and only a whole Warrant may be exercised, the Units may be worth less than units of other blank check companies.
  • A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.
  • Because we must furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.
  • We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
  • Compliance obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources, and increase the time and costs of completing our initial business combination.
  • Provisions in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A ordinary shares and could entrench management.
  • If we effect our initial business combination with a company with operations or opportunities outside of the United States, we would be subject to a variety of additional risks that may negatively impact our operations.
  • Our initial business combination and our structure thereafter may not be tax-efficient to our shareholders and warrantholders. As a result of our business combination, our tax obligations may be more complex, burdensome and uncertain.

Legal proceedings

There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
    SEC EDGAROther events
  19. 19
  20. 20
    SEC EDGAROther events
  21. 21
  22. 22
  23. 23
  24. 24
    SEC EDGAROther events
  25. 25
  26. 26
  27. 27
  28. 28
    SEC EDGAROther events
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40